Publishers of Quality Research

Bentham – Who we are?• We are a major international Scientific, Technical &

Medical publisher of 131 online and print journals, 200 plus open access journals, and related print/online more than 300 e-books, Bentham Science answers the informational needs of the pharmaceutical, biomedical and medical research community

• Leading publications include Current Gene Therapy, Current Drug Metabolism, Current Molecular Medicine and Current Medicinal Chemistry

• Bentham has experienced steady growth in subscriptions.

• Bentham Journals are endorsed by Nobel Laureates & leading scientists.

Our products: 131 journal titles in Print & Online

• Journal Catalog • New in 2014

Major Disciplines of Publications

which includes:

• Review Articles : Comprehensive, timely in-depth reviews on a given subject, written by leaders in the field.

• Original Papers : Cutting edge papers, published rapidly

Chemistry Drug Design & DiscoveryBiotechnology ImmunologyGenomics Molecular MedicineNeuroscience OncologyProteomics NanoscienceBioinformatics Drug Safety & TherapyPatent Information PharmacologyEngineering Biochemistry

For Academic and Pharmaceutical / Corporate  Libraries

• Applied Clinical Research, Clinical Trials and Regulatory Affairs

• Clinical Anti-Inflammatory & Anti-Allergy Drugs• Current Biochemical Engineering• Clinical Cancer Drugs• Clinical Cardiovascular Drugs• Current Chromatography• Current Environmental Engineering• Clinical Immunology, Endocrine & Metabolic Drugs• Current Green Chemistry• Current Microwave Chemistry• Clinical CNS Drugs• Current Organocatalysis

New in 2014: Review Journals in the Fields of

New Journals in 2014:

• Who are we: Bentham: a medium sized STM publisher of 130+ high quality niche (review) journals in innovative upcoming areas such as Physical Chemistry, Inorganic Chemistry and Patent information.

We publish the World's leading review journals in Molecular Medicine, Drug Metabolism, Alzheimer, Cancer Drug Design, Drug Targets and Medicinal Chemistry.

• We publish: High Impact Factor, well indexed journals 2 titles (Current Pharmaceutical Design & Current Medicinal

Chemistry) in the top 28 Impact Factor ranking in Pharmacology and Pharmacy

6 Nobel Laureates endorse our journals!

• Online access: Access via interface friendly platforms: Ingenta Connect, CrossRef, Infotrieve, Ebsco, Swetwise, J-Gate and Bentham Direct. We offer Counter compliant user statistics.

• Editors & authors: Are selected worldwide, all key players in their fields.

Important to know: 1/3

Important to know: 2/3

• Purchasing: We offer subject specific journal collections at good discounts to both library consortia and institutional libraries

• 3-month FREE Online Trial: extendable if necessary. Our marketing department will assist with promotion where required.

• Online back volumes: available at discount.

• Perpetual access is available for paid and subscribed volumes.

Important to know: 3/3

• Achievements: • 38 Bentham journals have registered Impact Factor ratings as per to journal citation report 2011

• 88 Subscription based journals received unofficial impact factor rankings, according to recently released Scopus (SCIMAGO) Citation Report 2011

• 19 Bentham Open Journals received unofficial impact factor rankings, according to recently released Scopus (SCIMAGO) Citation Report 2011

Nobel Laureates

Six Nobel laureates have endorsed a number of  Bentham Science journals

                                                                                     

 

                                                                                     

 

Nobel Laureates quote..

                                                                                     

 

Nobel Laureates quote..

Editorial Board / Authors

• A dominant element in the success of Bentham journals is the selection of key editors worldwide.

• Majority of publishing authors and editorial board members are from top international universities and research institutions in North America, Europe and Russia.

                                                                                     

 

Leading Impact Factors

ISI Journal Impact Factors 2012

Rank Journal TitlesImpactFactor

1 Current Gene Therapy 5.318

2 Current Drug Metabolism 4.405

3 Current Molecular Medicine 4.197

4 Current Medicinal Chemistry 4.07

5 Current Cancer Drug Targets 4.00

6 Current Drug Targets 3.848

7 CNS & Neurological Disorders- Drug Targets 3.769

8 Current Topics in Medicinal Chemistry 3.702

9 Current Alzheimer Research 3.676

10 Current Pharmaceutical Design 3.311

Leading Impact Factors

ISI Journal Impact Factors 2012

Rank Journal TitlesImpactFactor

11 Current Organic Chemistry 3.03912 Current Stem Cell Research & Therapy 2.96313 Mini- Reviews in Medicinal Chemistry  2.86514 Current Neurovascular Research 2.84415 Current Vascular Pharmacology 2.82116 Recent Patents on Anti-Cancer Drug Discov. 2.717 Current Pharmaceutical Biotechnology 2.69

18Anti-Cancer Agents in Medicinal Chemistry 2.61

19 Current Genomics 2.475

20 Current Protein & Peptide Science  2.326

Out of 131 titles published

• 52 titles are indexed in MEDLINE• 55 titles are indexed in Pub Med• 49 titles are indexed by ISI• 108 titles are indexed in Chemical Abstracts• 96 titles are indexed in SCOPUS• 73 titles are indexed by Google Scholar• 117 titles are indexed in J gate• 90 titles are indexed in Genomics Journal

Seek

Conditions: • Standard prices apply for single site (unlimited

users): consortia and multi-site or multi-subscription packages are negotiable.

• Cancellation of current subscriptions (print/online) is not accepted unless specifically agreed upon during negotiations, otherwise the consortium or multi-site/subscription deal ceases immediately.

• Subscriptions are on calendar year basis and pro-rated subscriptions are not allowed.

Innovations and news: 1/2

• Bentham has started an ambitious EBOOK program in 2009 and aim to publish many interesting EBooks in various disciplines , currently we have more than 300 eBooks

• Bentham also publishes 200+ open access journals in various disciplines

• Bentham is a member of CrossRef and all published articles have doi's submitted. Several titles (CMC, CPD, CTMC and CCHTS) offer referencing using the “Refine Resolution Service” through Ingenta Connect.

• Bentham has developed Bentham Direct its own journal hosting platform launched in August 2006: Full text pay per view access and online trials are available.

• Bentham Direct is COUNTER-Compliant .

Innovations and news: 2/2

• Partnering with conferences globally• Improving manuscript submission & tracking

• Advertising opportunities for print and online ads which provide effective communication channels to reach core group of researchers worldwide

• 38 Bentham journals have registered Impact Factor ratings as per to journal citation report 2011

Upcoming Conferences in Early 2014

• 6th International Conference on Drug Discovery & Therapy

February 10-12, 2014

Dubai, UAE

• 3rd Biotechnology World Congress

February 10-12, 2014

Dubai, UAE

• 247th American Chemical Society Spring National Meeting & Exposition

March 16-20, 2014

Dallas, Texas

Upcoming Conferences in Early 2014

• 20th Annual Conference & Exhibition of SLA-AGC

March 25-27 , 2014

Doha, Qatar

• American Association for Cancer Research

April 5-9, 2014

San Diego, USA

• UKSG Annual Conference

April 14-16, 2014

Harrogate, UK

Conclusion

• Bentham Science Publications are an immense value addition to your collection of journals

Please visit www.benthamscience.com for more information.